The Faustman Lab at Massachusetts General Hospital
Denise Faustman, MD, PhD, is Director of the Immunobiology
Laboratory at the Massachusetts General Hospital (MGH) and an Associate
Professor of Medicine at Harvard Medical School. Her current research
focuses on discovering and developing new treatments for type 1 diabetes
and other autoimmune diseases, including Crohn's disease, lupus,
scleroderma, rheumatoid arthritis, Sjögren's syndrome, and multiple
sclerosis. She is currently leading a human clinical trial program
testing the efficacy of the BCG vaccine for reversal of long-term type 1
diabetes. Positive results from the Phase I study were reported in 2012.Dr. Faustman's type 1 diabetes research has earned her notable awards such as the Oprah Achievement Award for “Top Health Breakthrough by a Female Scientist” (2005), the "Women in Science Award" from the American Medical Women’s Association and Wyeth Pharmaceutical Company for her contributions to autoimmune disease research (2006), and the Goldman Philanthropic Partnerships/Partnership for Cures “George and Judith Goldman Angel Award” for research to find an effective treatment for type 1 diabetes (2011). Her previous research accomplishments include the first scientific description of modifying donor tissue antigens to change their foreignness. This achievement earned her the prestigious National Institutes of Health and National Library of Medicine “Changing the Face of Medicine” Award (2003) as one of 300 American physicians (one of 35 in research) honored for seminal scientific achievements in the United States.
Dr. Faustman earned her MD and PhD from Washington University School of Medicine in St. Louis, Missouri, and completed her internship, residency, and fellowships in Internal Medicine and Endocrinology at the Massachusetts General Hospital in Boston, Massachusetts.
O Lab Faustman no Massachusetts General Hospital
Denise Faustman, MD, PhD, é diretor do Laboratório de Imunobiologia do Hospital Geral de Massachusetts (MGH) e professor associado de medicina na Harvard Medical School. A sua investigação actual visa a descoberta e desenvolvimento de novos tratamentos para a diabetes do tipo 1 e outras doenças auto-imunes, incluindo a doença de Crohn, lúpus, escleroderma, artrite reumatóide, síndroma de Sjogren e esclerose múltipla. Ela está atualmente conduzindo um programa de ensaio clínico em humanos testar a eficácia da vacina BCG para a reversão do diabetes a longo prazo do tipo 1. Um resultado positivo no estudo de Fase I foram relatados em 2012.
Diabetes investigação do Dr. Faustman tipo 1 lhe rendeu prêmios notáveis, como o Prêmio Oprah para "Breakthrough Top Saúde por um Cientista fêmea" (2005), "Mulheres em Ciência Award" da Associação de Mulheres American Medical e Wyeth Pharmaceutical Company para suas contribuições para a pesquisa da doença auto-imune (2006), e os Goldman filantrópicas Parcerias / Parceria para curas "George e Judith Goldman Anjo Award" para a pesquisa para encontrar um tratamento eficaz para o diabetes tipo 1 (2011). Suas realizações de pesquisas anteriores incluem a primeira descrição científica de modificar antígenos tecido do doador para mudar a sua estranheza. Esta conquista lhe rendeu o prestigioso National Institutes of Health e do National Library of Medicine "mudando a cara da medicina" Award (2003) como um dos 300 médicos norte-americanos (um de 35 em investigação) homenageados por conquistas científicas seminais nos Estados Unidos.
Nenhum comentário:
Postar um comentário